Company
Headquarters: Sha Tin, Hong Kong
Employees: 186
CEO: Mr. Ka Chun Wong
HK$2.70 Billion
HKD as of Jan. 1, 2025
US$348.0 Million
| Company | Market Cap (USD) |
|---|---|
| Lilly | $689.42 B |
| Novo Nordisk | $622.07 B |
| UnitedHealth Group | $487.54 B |
| Johnson & Johnson | $353.05 B |
| AbbVie | $301.60 B |
Tycoon Group Holdings Limited, an investment holding company, distributes a suite of health and well-being related products in Hong Kong, Mainland China, Macau, and Singapore. It operates through Distribution, E-Commerce, and Retail Stores segments. The company offers proprietary Chinese medicine, health supplement, skin care, personal care, and other healthcare products under the third-party and private label brands. It sells its products to chain retailers, non-chain retailers, and traders; and through its brick-and-mortar retail stores as well as online stores. The company was founded in 2015 and is headquartered in Shatin, Hong Kong.
Tycoon Group Holdings Ltd has the following listings and related stock indices.
Stock: HKEX: 3390 wb_incandescent